Dr. Tang Weikun, aged 36, joined Grand Pharma (China) Co., Ltd. (a major subsidiary of the Group) (“Grand Pharma (China)”) in 2012 and worked for several companies of the Group. He has been the assistant of the president of Grand Pharma (China) since April 2019 and was appointed as the president of Grand Pharma (China) with effect from 1 June 2021. Dr. Tang has overall responsibility for the operation of Grand Pharma (China). Dr. Tang completed his life science and technology undergraduate education at Wuhan University in 2007 and obtained his doctoral degree in microbiology from the College of Life Sciences, Wuhan University in 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
China Grand Pharmaceutical and Healthcare Holdings Ltd
China Grand Pharmaceutical and Healthcare Holdings Limited is a Hong Kong-based investment holding company principally engaged in the manufacture of pharmaceuticals. The main businesses of the Company include the research and development, manufacture and sales of pharmaceutical products, medical products, chemical products and healthcare products. The products of the Company include preparations, raw materials, medical devices, healthcare products, as well as agricultural and fine chemicals. Its products mainly focus on ophthalmic, cardiovascular and antibacterial, among others.